Livedo Reticularis

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?

Not FDA-cleared for livedo reticularis. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is investigational.

Какие доказательства существуют?

Tier C (investigational). Only anecdotal use; there are no randomized controlled trials. Most livedo cases are physiologic (cold-related, benign cutis marmorata) and require no therapy beyond warmth and reassurance. Secondary livedo reticularis (associated with antiphospholipid syndrome, systemic lupus erythematosus, vasculitis, polyarteritis nodosa, cholesterol emboli, thrombophilia, or drug exposure) requires identification and treatment of the underlying condition by rheumatology or appropriate specialty. Leech therapy is contraindicated in active inflammatory or thrombotic disease.

Основные риски

• Missed diagnosis of a serious underlying condition (APS, lupus, vasculitis, PAN) if leech therapy is pursued instead of full workup
• Bleeding from bite sites for 6 to 24 hours after detachment
• Bruising and tenderness over affected limbs for 5 to 10 days
• Local skin infection or, rarely, Aeromonas infection
• Allergic reaction to leech saliva (uncommon)
• Worsening of underlying inflammatory or thrombotic disease
• Permanent visible scars at bite sites

Кому не следует это рассматривать

• Patients with secondary livedo from an untreated underlying condition
• Patients with antiphospholipid syndrome with thrombosis history
• Patients on anticoagulants for APS, thrombophilia, or recurrent thrombosis
• Patients with active vasculitis, polyarteritis nodosa, or systemic lupus
• Patients with critical limb ischemia or recent cholesterol embolism
• Patients who have not had a rheumatologic and hematologic workup

О чём спросить врача

• Has the livedo been classified as primary (benign physiologic) or secondary?
• Have I been screened for antiphospholipid antibodies, ANA, complement, and a hypercoagulable workup?
• Are there other systemic symptoms (joint pain, fatigue, rashes, organ involvement) suggesting an autoimmune cause?
• Has a skin biopsy been considered if vasculitis or cholesterol emboli are possible?
• What is my management plan if a secondary cause is found?
• What evidence supports leech therapy for livedo specifically?
• What is the practitioner's experience and Aeromonas-prevention plan?

Когда срочно обратиться за медицинской помощью

• Sudden severe leg pain, coldness, pallor, or pulselessness (acute limb ischemia — call 911)
• New unilateral leg swelling, redness, and pain (possible DVT)
• New stroke-like symptoms (weakness, slurred speech, vision change) — could indicate APS
• Recurrent pregnancy loss (APS workup needed)
• Painful skin ulcers within livedo areas (livedoid vasculopathy or vasculitis)
• Fever, joint pain, kidney symptoms, or new rash (autoimmune flare)
• Hives, throat tightness, or breathing difficulty